The U.S. Food and Drug Administration (FDA) Approves Acalabrutinib (CALQUENCE) for Mantle Cell Lymphoma January 16, 2025 – On January 16, 2025, the U.S. Food and Drug Administration (FDA) announced it has approved acalabrutinib (CALQUENCE, AstraZeneca) with bendamustine and rituximab…
Many Ways to Support the Lymphoma Research Foundation By bringing together the promise of science and the power of people, a future without lymphoma is within our reach. Generosity from patients, friends, families, communities, and businesses fuels the mission of…
A Husband’s Devotion as His Wife Faced Lymphoma In 2015, Alex Wald, his wife, Alicia (Ali), and their 12-year-old son, Luke, were living a busy life in Crystal Beach, Florida, a picturesque beach town with shell-lined streets about 45 minutes…
From Personal Loss to Professional Passion: A Researcher’s Dedication to Transforming Patients’ Lives When Tycel Phillips, MD, of City of Hope, was a young child growing up in Chicago, his grandmother gave him an anatomy book as a gift. And…
A Donor’s Legacy Creates a Brighter Tomorrow Errol M. Cook, alongside his devoted wife, Gladys, served the Foundation as a Chair and member of the Board of Directors and supporter for more than 20 years. He worked closely with the…
Where Are They Now? John Pagel, MD, PhD When did you become interested in the study of medicine? In lymphoma specifically? When I was a kid, I was interested in two things: sports and science! Some of my earliest memories…
Lymphoma Research Foundation and Cutaneous Lymphoma Foundation Announce Strategic Collaboration to Accelerate T-cell Lymphoma Research and Advance Patient Education December 5, 2024 – The Lymphoma Research Foundation, the nation’s largest non-profit organization dedicated exclusively to funding innovative lymphoma research and…
Lymphoma Research Foundation Raises Over $1.3 Million at New York City Gala to Help Eradicate Lymphoma October 1, 2024 – The Lymphoma Research Foundation – the nation’s largest non-profit organization dedicated exclusively to funding innovative lymphoma research and serving the…
